Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease.

BACKGROUND: Inhaled morphine has previously been shown to increase exercise endurance in patients with chronic lung disease. A similar study was performed to determine whether inhaled morphine reduces the sensation of breathlessness in this group of patients. METHODS: A randomised double blind study on the effect of nebulised morphine on both exercise induced breathlessness and maximum achievable power output using isotonic saline as a control was performed in 10 patients with stable chronic lung disease. Each subject performed a progressive exercise test (Jones' stage I) on an electrically braked cycle ergometer. The work load was increased by 10 watts per minute and subjects exercised to exhaustion. At the end of each minute of exercise patients were asked to rate their degree of breathlessness according to a modified Borg scale. All subjects were randomised to receive either inhaled morphine sulphate 1 mg/ml (5 ml) or isotonic saline (5 ml) by wet nebulisation. The effect of morphine and saline on the achieved exercise capacity and the development of breathlessness during exercise was tested on separate days. RESULTS: The mean dose of morphine inhaled was 1.24 mg. There was no difference in maximum power output achieved, minute ventilation at maximum power output, nor the degree of breathlessness at maximum power output between the groups treated with morphine and placebo. The degree of breathlessness was related to the power output achieved during exercise by a power function relationship (mean r: morphine = 0.86, saline = 0.87). However, there was a wide variation in the sensation for any given power output in both groups. There was no difference in the group mean slopes (morphine = 1.15, saline = 1.00) or intercepts (morphine = 0.07, saline = 0.15) in this relationship between the morphine and saline treatment groups. CONCLUSIONS: In patients with severe chronic lung disease inhaled morphine in the doses used in this study does not relieve exercise induced breathlessness nor does it increase maximum power output achieved during progressive exercise.

[1]  J. W. Reed,et al.  Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease. , 1995, Thorax.

[2]  S. Teramoto Chronic lung disease and the perception of breathlessness: clinical perspective. , 1995, The European respiratory journal.

[3]  A. Rubinfeld,et al.  Chronic lung diseases and the perception of breathlessness: a clinical perspective. , 1994, The European respiratory journal.

[4]  J. Yernault,et al.  Perceived effect on shortness of breath of an acute inhalation of saline or terbutaline: variability and sensitivity of a visual analogue scale in patients with asthma or COPD. , 1992, The European respiratory journal.

[5]  N. Eiser,et al.  Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome. , 1991, The European respiratory journal.

[6]  E. Daviskas,et al.  Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease. , 1989, Thorax.

[7]  S. Brown,et al.  Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[8]  D. Bostwick,et al.  Expression of opioid peptides in tumors. , 1987, The New England journal of medicine.

[9]  G. Man,et al.  Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. , 1986, Chest.

[10]  P. O'Neill,et al.  Chlorpromazine--a specific effect on breathlessness? , 1985, British journal of clinical pharmacology.

[11]  P. O'Neill,et al.  Do prostaglandins have a role in breathlessness? , 1985, The American review of respiratory disease.

[12]  P. Sharman,et al.  Effects of codeine on the respiratory responses to exercise in healthy subjects. , 1983, British journal of clinical pharmacology.

[13]  A. Woodcock,et al.  Dihydrocodeine for breathlessness in "pink puffers". , 1983, British medical journal.

[14]  N. Jones Clinical Exercise Testing , 1982 .

[15]  A. Woodcock,et al.  Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. , 1981, The New England journal of medicine.

[16]  A. Woodcock,et al.  Endogenous opioids (endorphins) and the control of breathing. , 1981, The New England journal of medicine.

[17]  J. Lewis,et al.  Methods to assess breathlessness in healthy subjects: a critical evaluation and application to analyse the acute effects of diazepam and promethazine on breathlessness induced by exercise or by exposure to raised levels of carbon dioxide. , 1981, Clinical science.

[18]  D. Bar-Or,et al.  Endorphins and the control of breathing. , 1981, The New England journal of medicine.

[19]  A. Woodcock,et al.  Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. , 1981, British medical journal.

[20]  T. V. Santiago,et al.  Endorphins and the control of breathing. Ability of naloxone to restore flow-resistive load compensation in chronic obstructive pulmonary disease. , 1981, The New England journal of medicine.

[21]  K. Murphy,et al.  Diazepam in the treatment of dyspnoea in the 'Pink Puffer' syndrome. , 1980, The Quarterly journal of medicine.

[22]  G Borg,et al.  Subjective effort and physical abilities. , 1978, Scandinavian journal of rehabilitation medicine. Supplement.

[23]  J. Howell,et al.  Disproportionately severe breathlessness in chronic bronchitis. , 1969, The Quarterly journal of medicine.